S Merani, C Toso, J Emamaullee, AMJ … - British Journal of …, 2008 - ingentaconnect.com Background: Since the first report of successful pancreatic islet transplantation to reverse hyperglycaemia
in diabetic rodents, there has been great interest in determining the optimal site for
implantation. Although the portal vein remains the most frequently used site clinically, it is ... Cited by 7 - Related articles - All 4 versions
C Toso, V Serre-Beinier, J Emamaullee, S Merani, M … - Transplantation, 2008 - journals.lww.com Macrophage migration inhibitory factor (MIF) is a proin- flammatory cytokine expressed by numerous
cells and tissues throughout the body. It is associated with many immuno-inflammatory
disorders, including sepsis, adult re- spiratory distress syndrome, glomerulonephritis, ... Cited by 1 - Related articles - All 2 versions
JY Lim, BH Min, BG Kim, HJ Han, SJ Kim, CW Kim, SS … - Acta Diabetologica, 2009 - Springer Abstract Islet transplantation is a promising therapeutic option for type 1 diabetes, and actively
performed in the clinic as well as in the animal experiments. For the rodent experiments, islet
transplantation into kidney subcapsule is widely used to assess islet quality, however, it is ... Related articles - All 2 versions
Y Imai, Y Adachi, M Shi, C Shima, S Yanai, M … - Stem Cells and … - liebertonline.com Page 1. 1 Caspase Inhibitor, ZVAD-fmk, Facilitates Engraftment of Donor Hematopoietic
Stem Cells in Intra-Bone Marrow-Bone Marrow Transplantation Yuichiro Imai1,2, Yasushi
Adachi1,3,4, Ming Shi1, Chieko Shima1, Seiji Yanai1, ... Related articles - All 2 versions
AMJ Shapiro - Nature Clinical Practice Nephrology, 2008 - nature.com Professor James Shapiro is a clinical liver and multiorgan transplant and hepatobiliary oncology
surgeon at the University of Alberta in Edmonton, Canada. His clinical and experimental research
interests focus on islet replacement therapy for diabetes. He was the lead author of the ... Related articles - All 4 versions